Jared Whitlock


Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Illumina Reports 12 Percent Increase in Earnings

Illumina reported net income rose 12 percent year over year in first quarter earnings, reaching $233 million.

Antibiotic Developer Forge Therapeutics Inks Licensing Deal

Forge Therapeutics will license its platform to Basilea Pharmaceutica to create new antibiotics, it was announced April 24.

Funding Puts EvoFem in Position for Product Launch

Through a private stock placement Evofem Biosciences raised $30 million and said a second tranche is expected to provide up to $50 million more as the company gets closer to asking for regulatory approval of its birth control gel.

Avidity Biosciences Bags $35M Upfront from Eli Lilly

La Jolla’s Avidity Biosciences will receive $35 million upfront and potentially much more through a deal with Eli Lilly.

Scripps Launches Clinic for Inflammatory Breast Cancer

A clinic to diagnose, treat and monitor a rare form of breast cancer has launched at Scripps MD Anderson Cancer Center.

Poseida Therapeutics Raises $142M for Cancer Cell Therapy

Poseida is working to advance CAR-T therapy, in which a patient’s T cells are altered to kill cancer cells. The San Diego company developed what are called stem memory T cells. They aim to be safer — and last much longer — than early CAR-T products.

ECONOMY: San Diego Is a Clear Winner as Qualcomm's Stock Surges

The end of a royalty dispute that bogged down Qualcomm Inc., one of San Diego’s largest employers, looks to be a win for the region.

Tease photo

• AirporTour, a San Diego-based company that is building interactive airport guides with audio tours. • Ciari Guitars Inc., a San Diego-based startup that makes foldable travel guitars. The company p

A division of Rady Children’s Hospital that deploys quick-turnaround genomic sequencing in puzzling cases has added six board members.

Tease photo

PhaseBio Drug Receives ‘Breakthrough’ Designation

PhaseBio’s drug that aims to stop bleeding events received a breakthrough drug designation from the U.S. Food and Drug Administration. That follows an initial public offering and promising test results.

Tease photo

Salk Institute Receives $35M for Plant Initiative Fighting Climate Change

The Salk Institute for Biological Studies is set to receive $35 million to develop plants that suck up large amounts of carbon from the atmosphere to fight climate change.

More stories >>